US FDA May Grant More Emergency Use Authorizations For COVID-19 Treatments This Fall

 
• By Derrick Gingery

Convalescent plasma, anti-inflammatory agents among those that could be considered for EUAs, Commissioner Hahn says during congressional hearing on the coronavirus response.

Hahn_Stephen_US FDA Commissioner at House Energy and Commerce Committee 23 June 2020
FDA Commissioner Stephen Hahn appeared at the House committee hearing in-person, while most members offered questions via video conference. • Source: Screenshot

More from Review Pathways

More from Pathways & Standards